Komunikaty firm · 16.10.2026

Actinium Pharmaceuticals Announces Oral and Poster Presentations at EANM 2026 Highlighting Broad Antitumor Activity of ATNM-400 Across Lung, Colorectal and Ovarian Cancer Models

Actinium Pharmaceuticals will present oral and poster presentations at EANM 2026, highlighting the antitumor activity of ATNM-400 across various cancer models, including lung, colorectal, and ovarian cancer.